Siemens' Big Plans for AI and Life Sciences

Siemens AG's CEO, Roland Busch, has his eyes on the prize. He's looking at big moves in artificial intelligence, life sciences, and operations software. Why? Because he sees a future where data is king, especially in the life sciences. Last year, Siemens made a bold move. They spent $5. 1 billion on Dotmatics. This company is all about AI-driven drug development. Busch isn't done yet. He's hinting at more deals on the horizon.In a chat with Bloomberg Television, Busch dropped some hints. He talked about building a strong data backbone for life sciences. He believes this is super important. It's not just about making drugs. It's about using data to make better drugs, faster. But it's not just about life sciences. Siemens is also looking at operations software. This is the stuff that runs factories. It's the behind-the-scenes tech that keeps things moving. Busch sees potential here too. So, what's next for Siemens? They're not saying just yet. But one thing's for sure. They're not afraid to make big bets. And they're not done yet.